You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
錦藝(00565.HK)附屬擬投資生物技術公司
錦藝(00565.HK)公布,其間接全資附屬旭福與創始人股東杜劉東訂立不具法律約束力之意向書,旭福擬以股權、貸款或可換股債券等形式投資目標公司河北萬瑪生物醫藥,以及杜劉東擬與旭福訂立可能交易。 目標公司為一間生物技術公司,主要從事提供免疫細胞及幹細胞儲存服務,並開展腫瘤浸潤淋巴細胞、嵌合抗原受體T細胞療法、T細胞受體工程化T細胞療法、細胞因子誘導的殺傷細胞療法、淋巴因子激活的殺傷細胞、免疫檢查點抑制劑、誘導多能幹細胞等研究。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account